Regional

National Emergency Medical Services

May be outdated158 dose entries38 drugs23 documentsGAeffective 2024-09-0194% machine-parsed of 158

National Emergency Medical Services (GA) carries 38 drugs across 158 dose entries in its current published protocol, effective 2024-09-01.

The current listed document is more than 24 months old and may be outdated.

Drugs and doses38

Acetaminophen

Indication	Population	Dose	Route	Repeat	Standing	Source
Pediatric fever	peds	15 mg/kg	PO	not captured	standing	pages 21, 85, 92

Adenosine

Indication	Population	Dose	Route	Repeat	Standing	Source
SVT	adult	6 mg	IV	not captured	standing	pages 36, 37, 94, 95
SVT	peds	0.1 mg/kg	IV	not captured	standing	pages 36, 37, 94, 95

Albuterol

Indication	Population	Dose	Route	Repeat	Standing	Source
Asthma / bronchospasm	adult	2.5–5 mg	not captured	not captured	standing	pages 25, 26, 27, 52, 96
Asthma / bronchospasm	peds	2.5 mg	not captured	not captured	standing	pages 25, 26, 27, 52, 96
Hyperkalemia	adult	5 mg	not captured	not captured	standing	pages 61, 69

Amiodarone

Indication	Population	Dose	Route	Repeat	Standing	Source
Atrial fibrillation with RVR	adult	150 mg	IV/IO	not captured	standing	pages 36, 97, 98
Wide-complex tachycardia	adult	150 mg	IV/IO	not captured	standing	pages 36, 97, 99
Wide-complex tachycardia	peds	5 mg/kg	IV/IO	not captured	standing	pages 36, 97, 99
VF / pulseless VT	adult	300 mg	IV/IO	not captured	standing	pages 39, 43, 97, 99
VF / pulseless VT	adult	300 mg	IV/IO	not captured	standing	pages 39, 43, 97, 99
VF / pulseless VT	peds	5 mg/kg	IV/IO	not captured	standing	pages 39, 43, 97, 99
VF / pulseless VT	peds	5 mg/kg	IV/IO	not captured	standing	pages 39, 43, 97, 99

Aspirin

Indication	Population	Dose	Route	Repeat	Standing	Source
ACS / chest pain	adult	324 mg	PO	not captured	standing	pages 32, 100
ACS / chest pain	adult	324 mg	PO	not captured	standing	pages 32, 100

Atropine

Indication	Population	Dose	Route	Repeat	Standing	Source
Beta-blocker / calcium-channel-blocker overdose	peds	0.02 mg/kg	IV/IO	not captured	standing	page 44
Beta-blocker / calcium-channel-blocker overdose	peds	0.02 mg/kg	IV/IO	not captured	standing	page 44
Bradycardia	adult	0.5 mg	IV/IO	not captured	standing	pages 33, 34, 101, 102
Bradycardia	peds	0.02 mg/kg	IV/IO	not captured	standing	pages 33, 34, 101, 102
Organophosphate poisoning	adult	2 mg	IV/IO/IM	not captured	standing	pages 78, 86, 101, 102
Organophosphate poisoning	peds	0.02 mg/kg	IV/IO/IM	not captured	standing	pages 78, 86, 101, 102

Calcium Chloride

Indication	Population	Dose	Route	Repeat	Standing	Source
Beta-blocker / calcium-channel-blocker overdose	adult	1 g	IV/IO	not captured	standing	pages 40, 44, 103, 104
Beta-blocker / calcium-channel-blocker overdose	adult	1 g	IV/IO	not captured	standing	pages 40, 44, 103, 104
Beta-blocker / calcium-channel-blocker overdose	peds	20 mg/kg	IV/IO	not captured	standing	pages 40, 44, 103, 104
Beta-blocker / calcium-channel-blocker overdose	peds	20 mg/kg	IV/IO	not captured	standing	pages 40, 44, 103, 104
Hyperkalemia	adult	1 g	IV/IO	not captured	standing	pages 40, 61, 103, 104
Hyperkalemia	peds	20 mg/kg	IV/IO	not captured	standing	pages 40, 61, 103, 104

Dextrose

Indication	Population	Dose	Route	Repeat	Standing	Source
Hypoglycemia	adult	12.5 g	IV/IO	not captured	standing	pages 60, 105, 106
Hypoglycemia	peds	0.5 g/kg	IV/IO	not captured	standing	pages 60, 105, 106
Other	adult	25 g	IV/IO	not captured	standing	page 105

Diazepam

Indication	Population	Dose	Route	Repeat	Standing	Source
Seizure	adult	5 mg	IV/IO/IM	not captured	standing	pages 107, 108
Seizure	peds	0.2 mg/kg	IV/IO/IM	not captured	standing	pages 107, 108

Diltiazem

Indication	Population	Dose	Route	Repeat	Standing	Source
Atrial fibrillation with RVR	adult	10 mg	IV/IO	not captured	standing	pages 109, 110

Diphenhydramine

Indication	Population	Dose	Route	Repeat	Standing	Source
Agitation	adult	25–50 mg	IM	not captured	standing	page 51
Agitation	adult	25–50 mg	IM	not captured	standing	page 51
Allergic reaction	adult	25–50 mg	IV/IO/IM	not captured	standing	pages 111, 112
Allergic reaction	peds	1 mg/kg	IV/IO/IM	not captured	standing	pages 111, 112
Anaphylaxis	adult	25–50 mg	IV/IO/IM	not captured	standing	pages 52, 111, 112
Anaphylaxis	peds	1 mg/kg	IV/IO/IM	not captured	standing	pages 52, 111, 112
Dystonic reaction	adult	25–50 mg	IV/IO/IM	not captured	standing	pages 20, 111, 112
Dystonic reaction	peds	1 mg/kg	IV/IO/IM	not captured	standing	pages 20, 111, 112
Other	adult	25–50 mg	IV/IO/IM	not captured	standing	pages 111, 112
Other	peds	1 mg/kg	IV/IO/IM	not captured	standing	pages 111, 112

Epinephrine

Indication	Population	Dose	Route	Repeat	Standing	Source
Anaphylaxis	adult	0.3 mg	IM	not captured	standing	pages 52, 113
Anaphylaxis	peds	0.15 mg	IM	not captured	standing	pages 52, 113
Asthma / bronchospasm	adult	0.3 mg	IM/SQ	not captured	standing	page 113
Asthma / bronchospasm	peds	0.01 mg/kg	IM/SQ	not captured	standing	page 113
Bradycardia	adult	2.5–10 mcg	IV/IO	not captured	standing	pages 33, 34, 113, 115
Bradycardia	peds	0.01 mg/kg	IV/IO	not captured	standing	pages 33, 34, 113, 115
Cardiac arrest	adult	1 mg	IV/IO	not captured	standing	pages 39, 43, 113, 116
Cardiac arrest	peds	0.01 mg/kg	IV/IO	not captured	standing	pages 39, 43, 113, 116
Croup	peds	2.5 mL	NEB	not captured	standing	pages 26, 113
Hypotension / shock	adult	10 mcg	IV/IO	not captured	standing	pages 41, 63, 113, 118, 119, 120
Hypotension / shock	peds	1 mcg/kg	IV/IO	not captured	standing	pages 41, 63, 113, 118, 119, 120
Stridor	peds	2.5 mg	NEB	not captured	standing	pages 68, 113

Etomidate

Indication	Population	Dose	Route	Repeat	Standing	Source
RSI induction	adult	0.3 mg/kg	IV/IO	not captured	standing	pages 28, 121

Fentanyl

Indication	Population	Dose	Route	Repeat	Standing	Source
Mild to moderate pain	adult	1–2 mcg/kg	IV/IO/IM/IN	not captured	standing	pages 21, 122, 123
Mild to moderate pain	peds	1 mcg/kg	IV/IO/IM/IN	not captured	standing	pages 21, 122, 123
Procedural sedation	adult	1–2 mcg/kg	IV/IO	not captured	standing	pages 28, 122

Furosemide

Indication	Population	Dose	Route	Repeat	Standing	Source
CHF / pulmonary edema	adult	40 mg	IV	not captured	standing	page 124

Glucagon

Indication	Population	Dose	Route	Repeat	Standing	Source
Anaphylaxis	adult	1 mg	IV/IO	not captured	standing	page 125
Anaphylaxis	peds	0.1 mg/kg	IV/IO	not captured	standing	page 125
Beta-blocker / calcium-channel-blocker overdose	adult	5–10 mg	IV/IO	not captured	standing	pages 40, 44, 125
Beta-blocker / calcium-channel-blocker overdose	adult	5–10 mg	IV/IO	not captured	standing	pages 40, 44, 125
Beta-blocker / calcium-channel-blocker overdose	peds	0.5 mg	IV/IO	not captured	standing	pages 40, 44, 125
Beta-blocker / calcium-channel-blocker overdose	peds	0.5 mg	IV/IO	not captured	standing	pages 40, 44, 125
Hypoglycemia	adult	1 mg	IM/IN	not captured	standing	pages 60, 125
Hypoglycemia	peds	0.1 mg/kg	IM/IN	not captured	standing	pages 60, 125

Haloperidol

Indication	Population	Dose	Route	Repeat	Standing	Source
Agitation	adult	5 mg	IM	not captured	standing	pages 51, 126, 127
Agitation	peds	0.15 mg/kg	IM	not captured	standing	pages 51, 126, 127
Other	adult	5 mg	IM	not captured	standing	pages 51, 126, 127
Other	peds	0.15 mg/kg	IM	not captured	standing	pages 51, 126, 127

Ibuprofen

Indication	Population	Dose	Route	Repeat	Standing	Source
Mild to moderate pain	peds	10 mg/kg	PO	not captured	standing	pages 21, 128, 129
Pediatric fever	peds	10 mg/kg	PO	not captured	standing	pages 21, 85, 128, 129

Ipratropium

Indication	Population	Dose	Route	Repeat	Standing	Source
Asthma / bronchospasm	adult	0.5 mg	not captured	not captured	standing	pages 25, 26, 27, 52, 130
Asthma / bronchospasm	adult	0.5 mg	not captured	not captured	standing	pages 25, 26, 27, 52, 130
Asthma / bronchospasm	peds	0.5 mg	not captured	not captured	standing	pages 25, 26, 27, 52, 130
Asthma / bronchospasm	peds	0.5 mg	not captured	not captured	standing	pages 25, 26, 27, 52, 130

Ketamine

Indication	Population	Dose	Route	Repeat	Standing	Source
Agitation	adult	1 mg/kg	IM/IN	not captured	standing	pages 27, 131
Agitation	peds	1 mg/kg	IM/IN	not captured	standing	pages 27, 131
Mild to moderate pain	adult	0.25 mg/kg	IV/IO/IM	not captured	standing	pages 21, 131
Mild to moderate pain	peds	0.25 mg/kg	IV/IO/IM	not captured	standing	pages 21, 131
RSI induction	adult	2 mg/kg	IV	not captured	standing	pages 28, 131

Ketorolac

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	15–30 mg	IV/IO/IM	not captured	standing	pages 21, 132
Mild to moderate pain	adult	15–30 mg	IV/IO/IM	not captured	standing	pages 21, 132
Mild to moderate pain	adult	15–30 mg	IV/IO/IM	not captured	standing	pages 21, 132

Labetalol

Indication	Population	Dose	Route	Repeat	Standing	Source
Eclampsia / pre-eclampsia	adult	20 mg	IV	not captured	standing	pages 88, 133
Other	adult	10 mg	IV	not captured	standing	page 133

Lidocaine

Indication	Population	Dose	Route	Repeat	Standing	Source
Mild to moderate pain	adult	40 mg	IO	not captured	standing	pages 19, 134, 135
Mild to moderate pain	peds	0.5 mg/kg	IO	not captured	standing	pages 19, 134, 135
VF / pulseless VT	adult	1 mg/kg	IV/IO	not captured	standing	pages 134, 173
VF / pulseless VT	peds	1 mg/kg	IV/IO	not captured	standing	pages 134, 173

Lorazepam

Indication	Population	Dose	Route	Repeat	Standing	Source
Hyperactive delirium	adult	1–2 mg	IV/IO/IM	not captured	standing	pages 136, 137
Hyperactive delirium	peds	0.1 mg/kg	IV/IO/IM	not captured	standing	pages 136, 137
Seizure	adult	1–2 mg	IV/IO/IM	not captured	standing	pages 136, 137
Seizure	peds	0.1 mg/kg	IV/IO/IM	not captured	standing	pages 136, 137

Magnesium Sulfate

Indication	Population	Dose	Route	Repeat	Standing	Source
Asthma / bronchospasm	adult	2 g	IV	not captured	standing	pages 25, 138, 139, 140
Asthma / bronchospasm	peds	50 mg/kg	IV	not captured	standing	pages 25, 138, 139, 140
Eclampsia / pre-eclampsia	peds	50 mg/kg	IV/IO/IM	not captured	standing	pages 64, 138, 139
VF / pulseless VT	adult	2–4 g	IV/IO	not captured	standing	pages 138, 139

Methylprednisolone

Indication	Population	Dose	Route	Repeat	Standing	Source
Anaphylaxis	adult	125 mg	IV/IO/IM	not captured	standing	pages 52, 141, 142
Anaphylaxis	peds	2 mg/kg	IV/IO/IM	not captured	standing	pages 52, 141, 142
Asthma / bronchospasm	adult	125 mg	IV/IO/IM	not captured	standing	pages 25, 141, 142
Asthma / bronchospasm	peds	2 mg/kg	IV/IO/IM	not captured	standing	pages 25, 141, 142
Other	adult	125 mg	IV/IO/IM	not captured	standing	pages 25, 27, 141, 142
Other	peds	2 mg/kg	IV/IO/IM	not captured	standing	pages 25, 27, 141, 142

Midazolam

Indication	Population	Dose	Route	Repeat	Standing	Source
Agitation	adult	2.5 mg	IV/IO/IM/IN	not captured	standing	page 21
Agitation	peds	0.1 mg/kg	IV/IO/IM/IN	not captured	standing	page 21
Hyperactive delirium	adult	2.5–5 mg	IV/IO/IM/IN	not captured	standing	pages 143, 144
Hyperactive delirium	peds	0.1–0.2 mg/kg	IV/IO/IM/IN	not captured	standing	pages 143, 144
Procedural sedation	adult	2.5 mg	IV/IO/IM/IN	not captured	standing	page 33
Seizure	adult	2.5–5 mg	IV/IO/IM/IN	not captured	standing	pages 64, 143, 144
Seizure	peds	0.1–0.2 mg/kg	IV/IO/IM/IN	not captured	standing	pages 64, 143, 144

Morphine

Indication	Population	Dose	Route	Repeat	Standing	Source
Severe pain	adult	4 mg	IV/IO/IM/IN	not captured	standing	pages 21, 145
Severe pain	peds	0.1 mg/kg	IV/IO/IM/IN	not captured	standing	pages 21, 145

Naloxone

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	0.4–2 mg	IV/IO/IN	not captured	standing	pages 40, 86
Other	peds	0.1 mg/kg	IN	not captured	standing	pages 40, 78, 86
Other	peds	0.1 mg/kg	IV/IO/IN	not captured	standing	pages 40, 86

Nitroglycerin

Indication	Population	Dose	Route	Repeat	Standing	Source
ACS / chest pain	adult	0.4 mg	SL	not captured	standing	pages 32, 147
ACS / chest pain	adult	1 inch	TD	not captured	standing	pages 32, 147
CHF / pulmonary edema	adult	0.4 mg	SL	not captured	standing	page 57
CHF / pulmonary edema	adult	1 inch	TD	not captured	standing	page 57

Norepinephrine

Indication	Population	Dose	Route	Repeat	Standing	Source
Hypotension / shock	adult	5–30 mcg	IV/IO	not captured	standing	pages 32, 41, 63, 148
Hypotension / shock	peds	0.1–1 mcg/kg	IV/IO	not captured	standing	pages 32, 41, 63, 148
Other	adult	5–30 mcg	IV/IO	not captured	standing	page 148
Other	peds	0.1–1 mcg/kg	IV/IO	not captured	standing	page 148

Ondansetron

Indication	Population	Dose	Route	Repeat	Standing	Source
Nausea / vomiting	adult	4 mg	IV/ODT	not captured	standing	pages 20, 153, 154
Nausea / vomiting	adult	4 mg	IV/ODT	not captured	standing	pages 20, 153, 154
Nausea / vomiting	peds	0.1 mg/kg	IV/ODT	not captured	standing	pages 20, 153, 154
Nausea / vomiting	peds	0.1 mg/kg	IV/ODT	not captured	standing	pages 20, 153, 154

Oral Glucose

Indication	Population	Dose	Route	Repeat	Standing	Source
Hypoglycemia	adult	15–30 g	PO	not captured	standing	pages 60, 155
Hypoglycemia	peds	7.5–15 g	PO	not captured	standing	pages 60, 155

Prochlorperazine

Indication	Population	Dose	Route	Repeat	Standing	Source
Nausea / vomiting	adult	5 mg	IV/IM	not captured	standing	pages 20, 157
Nausea / vomiting	adult	5 mg	IV/IM	not captured	standing	pages 20, 157

Racemic Epinephrine

Indication	Population	Dose	Route	Repeat	Standing	Source
Croup	adult	11.25 mg	not captured	not captured	standing	pages 26, 158
Stridor	adult	11.25 mg	not captured	not captured	standing	pages 25, 26, 158

Sodium Bicarbonate

Indication	Population	Dose	Route	Repeat	Standing	Source
Hyperkalemia	adult	1 mEq/kg	IV/IO	not captured	standing	pages 40, 159
Hyperkalemia	peds	1 mEq/kg	IV/IO	not captured	standing	pages 40, 159
Other	adult	1 mEq/kg	IV	not captured	standing	pages 69, 159
Other	adult	1 mEq/kg	IV/IO	not captured	standing	pages 78, 159
Other	adult	1 mEq/kg	IV/IO	not captured	standing	page 159
Other	peds	1 mEq/kg	IV	not captured	standing	pages 69, 159
Other	peds	1 mEq/kg	IV/IO	not captured	standing	pages 78, 159
Other	peds	1 mEq/kg	IV/IO	not captured	standing	page 159
Tricyclic overdose	adult	1 mEq/kg	IV/IO	not captured	standing	pages 40, 78, 159
Tricyclic overdose	peds	1 mEq/kg	IV/IO	not captured	standing	pages 40, 78, 159

Thiamine

Indication	Population	Dose	Route	Repeat	Standing	Source
Hypoglycemia	adult	100 mg	IV/IO	not captured	standing	pages 60, 161
Hypoglycemia	peds	10–25 mg	IV/IO	not captured	standing	pages 60, 161
Other	adult	100 mg	IV/IO	not captured	standing	pages 105, 161
Other	adult	100 mg	IV/IO	not captured	standing	pages 60, 161
Other	adult	100 mg	IV/IO	not captured	standing	pages 60, 161
Other	peds	10–25 mg	IV/IO	not captured	standing	pages 105, 161
Other	peds	10–25 mg	IV/IO	not captured	standing	pages 60, 161
Other	peds	10–25 mg	IV/IO	not captured	standing	pages 60, 161

Tranexamic Acid

Indication	Population	Dose	Route	Repeat	Standing	Source
Trauma / hemorrhage	adult	2 g	IV	not captured	standing	pages 42, 66, 67, 162
Trauma / hemorrhage	adult	2 g	IV	not captured	standing	pages 66, 67, 162
Trauma / hemorrhage	peds	15 mg/kg	IV	not captured	standing	pages 42, 66, 67, 162
Trauma / hemorrhage	peds	15 mg/kg	IV	not captured	standing	pages 66, 67, 162

Cite this

National Emergency Medical Services, United States EMS Protocol Census. 158 dose entries, effective 2024-09-01.

https://protoquiz.com/census/agencies/national-emergency-medical-services/

Outdated or wrong?

Send the current document's public URL and the listing is rebuilt from it. To have this agency removed from the census entirely, say so and it comes down the same day.